IBM and the University of the Witwatersrand in Johannesburg have inaugurated the Pan-African Quantum Computational Biology Network, linking 14 African academic institutions directly to IBM Quantum System Two processors.

The collaborative initiative simulates complex protein-ligand bindings to predict drug resistance pathways in Mycobacterium tuberculosis strains specific to the sub-Saharan region, compressing simulation schedules from months to hours.

This partnership provides African researchers with direct cloud access to state-of-the-art 1,000+ qubit processors, democratizing cutting-edge drug discovery tools previously centralized in North America and Europe.